Timoptol LA 0.5% w/v Gel-Forming Eye Drops Solution

Pajjiż: Ingilterra

Lingwa: Ingliż

Sors: myHealthbox

Ingredjent attiv:

timolol maleate

Disponibbli minn:

Santen Oy

Kodiċi ATC:

C07AA01

INN (Isem Internazzjonali):

timolol maleate

Dożaġġ:

0.5% w/v

Għamla farmaċewtika:

Sterile gel-forming eye drops solution.

Rotta amministrattiva:

ocular route

Unitajiet fil-pakkett:

2.5 ml of solution

Tip ta 'preskrizzjoni:

POM - Prescription Only Medicine

Manifatturat minn:

Laboratories Merck Sharp & Dohme

Grupp terapewtiku:

Beta-adrenergic receptor blocking agent

Indikazzjonijiet terapewtiċi:

A beta-adrenoreceptor blocker used topically in the reduction of elevated intra-ocular pressure in various conditions including the following: patients with ocular hypertension; patients with chronic open-angle glaucoma including aphakic patients; some patients with secondary glaucoma.

L-istatus ta 'awtorizzazzjoni:

Authorised

Data ta 'l-awtorizzazzjoni:

2015-07-31

Fuljett ta 'informazzjoni

Profile: 
PB00-2_SP11031
Profile Revision: 
C
Profile Revision Date:  140111
Dimensions (mm): 
160 x 315
Black
Profile
Technical Info
Item No.:
Revision Date & No.:
Pharma Code:
MBS Job No.: 
517228Z
030415-1
524
362642
ITEM# and REVISION#
in OCRB font 
Horizontal Scale 71%
Size 5 points
PACKAGE LEAFLET: INFORMATION FOR THE USER
TIMOPTOL®-LA 0.25% W/V GEL-FORMING EYE DROPS SOLUTION
TIMOPTOL®-LA 0.5% W/V GEL-FORMING EYE DROPS SOLUTION
TIMOLOL (AS MALEATE)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE.
-  Keep this leaflet. You may need to read it again.
-  If you have any further questions, ask your doctor or pharmacist.
-  This medicine has been prescribed for you. Do not pass it on to
others. It may harm them, even if their 
symptoms are the same as yours.
-  If any of the side effects gets serious, or if you notice any
side effects not listed in this leaflet, please tell your 
doctor or pharmacist.
IN THIS LEAFLET:
1.  What Timoptol-LA is and what it is used for
2.  Before you use Timoptol-LA
3.  How to use Timoptol-LA
4.  Possible side effects
5.  How to store Timoptol-LA
6.  Further information
1.  WHAT TIMOPTOL-LA IS AND WHAT IT IS USED FOR
Timoptol-LA contains a substance called timolol which belongs to a
group of medicines called beta-blockers. 
Timolol lowers the pressure in your eye(s). It is used to treat
glaucoma, when the pressure in the eye is raised.
2.  BEFORE YOU USE TIMOPTOL-LA
DO NOT USE TIMOPTOL-LA IF:
•  you are allergic (hypersensitive) to timolol, beta-blockers or
any of the other ingredients of Timoptol-LA 
(see section 6 for Further Information)
•  you have now or have had in the past respiratory problems such
as asthma, severe chronic obstructive 
bronchitis (severe lung disease which may cause wheeziness, difficulty
in breathing and/or long-standing 
cough).
•  you have heart problems
•  slow heartbeat
•  disorders of heart rhythm (irregular heart beats)
•  heart failure
-  “cardiog

Karatteristiċi tal-prodott

7LPRSWRODQGZY(\H'URSV6ROXWLRQ
6XPPDU\RI3URGXFW&KDUDFWHULVWLFV8SGDWHG'HF_6DQWHQ8./LPLWHG
1DPHRIWKHPHGLFLQDOSURGXFW
7LPRSWROŠZY(\H'URSV6ROXWLRQ
7LPRSWROŠZY(\H'URSV6ROXWLRQ
4XDOLWDWLYHDQGTXDQWLWDWLYHFRPSRVLWLRQ
7LPRSWRO
ZY(\H'URSV6ROXWLRQFRQWDLQVWLPROROPDOHDWHHTXLYDOHQWWRZYVROXWLRQRIWLPROROZLWK
SUHVHUYDWLYH
7LPRSWRO
ZY(\H'URSV6ROXWLRQFRQWDLQVWLPROROPDOHDWHHTXLYDOHQWWRZYVROXWLRQRIWLPROROZLWK
SUHVHUYDWLYH
3KDUPDFHXWLFDOIRUP
(\HGURSVVROXWLRQ
&OHDUFRORXUOHVVWROLJKW\HOORZVWHULOHH\HGURSVVROXWLRQ
&OLQLFDOSDUWLFXODUV
7KHUDSHXWLFLQGLFDWLRQV
7LPRSWRO
(\H'URSV6ROXWLRQLVDEHWDDGUHQRUHFHSWRUEORFNLQJDJHQWXVHGWRSLFDOO\LQWKHUHGXFWLRQRIHOHYDWHGLQWUD
RFXODUSUHVVXUHLQYDULRXVFRQGLWLRQVLQFOXGLQJIROORZLQJSDWLHQWVZLWKRFXODUK\SHUWHQVLRQSDWLHQWVZLWKFKURQLFRSHQ
DQJOHJODXFRPDLQFOXGLQJDSKDNLFSDWLHQWVVRPHSDWLHQWVZLWKVHFRQGDU\JODXFRPD
3RVRORJ\DQGPHWKRGRIDGPLQLVWUDWLRQ
5HFRPPHQGHGWKHUDS\LVRQHGURSVROXWLRQLQWKHDIIHFWHGH\HWZLFHDGD\
:KHQXVLQJQDVRODFULPDORFFOXVLRQRUFORVLQJWKHH\HOLGVIRUPLQXWHVWKHV\VWHPLFDEVRUSWLRQLVUHGXFHG7KLVPD\
UHVXOWLQDGHFUHDVHLQV\VWHPLFVLGHHIIHFWVDQGDQLQFUHDVHLQORFDODFWLYLW\
,IFOLQLFDOUHVSRQVHLVQRWDGHTXDWHGRVDJHPD\EHFKDQJHGWRRQHGURSVROXWLRQLQHDFKDIIHFWHGH\HWZLFHD
GD\,IQHHGHG 7LPRSWRO
PD\EHXVHGZLWKRWKHUDJHQWVIRUORZHULQJLQWUDRFXODUSUHVVXUH7KHXVHRIWZRWRSLFDO
EHWDDGUHQHUJLFEORFNLQJDJHQWVLVQRWUHFRPPHQGHGVHH
6SHFLDOZDUQLQJVDQGSUHFDXWLRQVIRUXVH
,QWUDRFXODUSUHVVXUHVKRXOGEHUHDVVHVVHGDSSUR[LPDWHO\IRXUZHHNVDIWHUVWDUWLQJWUHDWPHQWEHFDXVHUHVSRQVHWR
7LPRSWRO PD\WDNHDIHZZHHNVWRVWDELOLVH
3URYLGHGWKDWWKHLQWUDRFXODUSUHVVXUHLVPDLQWDLQHGDWVDWLVIDFWRU\OHYHOVPDQ\SDWLHQWVFDQWKHQEHSODFHGRQRQFH
DGD\WKHUDS\
_7UDQVIHUIURPRWKHUDJHQWV_
:KHQDQRWKHUWRSLFDOEHWDEORFNLQJDJHQWLVEHLQJXVHGG